LoQus23 Therapeutics
Stopping DNA instability; Slowing neurodegenerative disease
- Business Model
- B2B
- Website
- loqus23.com
- Total Funding
- $43.0M
- Last Round
- $43.0M Series AOct 2024
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Therapeutic development
Summary
LoQus23 Therapeutics is a Biotech company. It has raised $43.0M in total across 2 rounds, most recently a $43.0M Series A round in Oct 2024. Investors include Forbion Capital Partners, Dementia Discovery Fund and Novartis Venture Fund.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2024
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/loqus23-therapeutics"><img src="https://indexed.vc/api/badge/company/loqus23-therapeutics" alt="LoQus23 Therapeutics on Indexed.vc" width="260" height="76" /></a>